Park Ha Biological Technology is trading at $3.86, up +22.89%, with the reason unconfirmed pending additional company news or filings.
- No clear company-specific catalyst was identified for August 10, 2026.
- The stock remains highly volatile after its 1-for-8 reverse stock split, effective August 6, reducing shares outstanding from approximately 18.76 million to roughly 2.35 million.
- Broader markets are mixed, so macro sentiment does not clearly explain the gain.